Clin2
NCT05891145Possibly a fitRecruiting

Remimazolam to prevent irregular heartbeat after heart surgery

Coronary Artery Bypass GraftingRemimazolam

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether a medication called remimazolam can help prevent atrial fibrillation—a common, irregular heart rhythm that can happen after surgery. It focuses on people having a specific planned type of heart bypass surgery and checks if the study medication reduces postoperative rhythm problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
50 years to 70 years
Study type
Interventional

Who can take part

  • Be 50 to 70 years old
  • Have a body mass index (BMI) between 18 and 28
  • Be scheduled for planned selective CABG (heart bypass) surgery at the study hospital in Yangzhou, China
  • Have no irregular fast heart rhythm (supraventricular arrhythmia) before surgery
  • You must agree to take part and sign informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06716840Recruiting
Remimazolam for sedation after heart surgery

This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.

Hangzhou, Zhejiang
NCT07674719Not yet recruiting
Remimazolam anesthesia to prevent kidney injury after liver or pancreas surgery

This study is testing whether the anesthesia drug remimazolam can help protect your kidneys after liver or pancreas surgery. It's comparing it to a standard anesthesia drug to see if it reduces the chances of kidney injury after the operation.

Seongnam-si, Gyeonggi-do
NCT07290205Recruiting· Early Phase 1
Remimazolam brain imaging study

This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.

Pittsburgh, Pennsylvania
NCT07725185Enrolling by invitation
Can remimazolam protect heart health during surgery?

This study tests whether a sedative called remimazolam can help protect the heart during surgery in older adults. If you are 65 or older and having a longer surgery with general anesthesia, this trial may be for you.

Jiaxing, Zhejiang
NCT06496165Not yet recruiting
Sedative comparison for blood pressure after heart bypass surgery

This study compares two sedatives (remimazolam and propofol) given to people after coronary bypass surgery to see which one better keeps blood pressure stable while they are on a breathing tube in the intensive care unit.

Shanghai, Shanghai Municipality
NCT05728775Recruiting· Phase 4
Comparing two anesthetics after major non-heart surgery

This trial compares the anesthesia medicines remimazolam and propofol during major surgery to see how patients do afterward. It may help guide which anesthetic is safer or leads to better recovery in higher-risk patients.

Hefei, Anhui

Hear when a new Coronary Artery Bypass Grafting trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.